The magic to killing cancer cells might not be in the bullet, but in the gunpowder that accompanies it, according to researchers at the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter. Instead ...
Nov 15, 2013
0
0
(Medical Xpress)—Researchers at the Virginia Bioinformatics Institute have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of ...
Sep 24, 2013
0
0
Neuroblastomas are pediatric tumors that originate from cells of the embryonic nervous system. The disease can take widely varying clinical courses that range from spontaneous regression to fatal outcomes. Highly aggressive ...
Jul 1, 2013
0
0
(Medical Xpress)—Oral supplementation of glutathione is effective in increasing the body's stores of the antioxidant, said Penn State College of Medicine researchers in study results presented at a conference today (April ...
Apr 23, 2013
0
0
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. ...
Dec 4, 2012
0
0
There are plenty of effective anticancer agents around. The problem is that, very often, they cannot gain access to all the cells in solid tumors. A new gene delivery vehicle may provide a way of making tracks to the heart ...
Nov 14, 2012
0
0
Mice have made an immeasurable contribution to medicine and our overall understanding of human disease. This animal model is not without its limitations, however, and scientists are continually learning about important ways ...
Oct 24, 2012
0
0
To transport substances from the site of their production to their destination, the body needs a sophisticated transport and sorting system. Various receptors in and on the cells recognize certain molecules, pack them and ...
Oct 18, 2012
0
0
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new "first response" mechanism that the immune system uses to respond to infection. The findings challenge the current understanding ...
Aug 30, 2012
0
0
Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.
Aug 7, 2012
0
0
